Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

October 13, 2015; 85 (15) Article

Basal ganglia pathology in ALS is associated with neuropsychological deficits

Judith Machts, Kristian Loewe, Joern Kaufmann, Sibylle Jakubiczka, Susanne Abdulla, Susanne Petri, Reinhard Dengler, Hans-Jochen Heinze, Stefan Vielhaber, Mircea Ariel Schoenfeld, Peter Bede
First published September 18, 2015, DOI: https://doi.org/10.1212/WNL.0000000000002017
Judith Machts
From the German Center for Neurodegenerative Diseases (J.M., S.A., H.-J.H., S.V.), Magdeburg; Departments of Neurology (J.M., K.L., J.K., S.A., H.-J.H., S.V., M.A.S.) and Knowledge and Language Processing (K.L.), and Institute for Human Genetics (S.J.), Otto-von-Guericke University, Magdeburg; Department of Neurology (S.A., S.P., R.D.), Hannover Medical School; Leibniz Institute for Neurobiology (H.-J.H., M.A.S.), Magdeburg; Kliniken Schmieder (M.A.S.), Allensbach, Germany; and Quantitative Neuroimaging Group (P.B.), Academic Unit of Neurology, Trinity College Dublin, Ireland.
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristian Loewe
From the German Center for Neurodegenerative Diseases (J.M., S.A., H.-J.H., S.V.), Magdeburg; Departments of Neurology (J.M., K.L., J.K., S.A., H.-J.H., S.V., M.A.S.) and Knowledge and Language Processing (K.L.), and Institute for Human Genetics (S.J.), Otto-von-Guericke University, Magdeburg; Department of Neurology (S.A., S.P., R.D.), Hannover Medical School; Leibniz Institute for Neurobiology (H.-J.H., M.A.S.), Magdeburg; Kliniken Schmieder (M.A.S.), Allensbach, Germany; and Quantitative Neuroimaging Group (P.B.), Academic Unit of Neurology, Trinity College Dublin, Ireland.
Dipl-Inf
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joern Kaufmann
From the German Center for Neurodegenerative Diseases (J.M., S.A., H.-J.H., S.V.), Magdeburg; Departments of Neurology (J.M., K.L., J.K., S.A., H.-J.H., S.V., M.A.S.) and Knowledge and Language Processing (K.L.), and Institute for Human Genetics (S.J.), Otto-von-Guericke University, Magdeburg; Department of Neurology (S.A., S.P., R.D.), Hannover Medical School; Leibniz Institute for Neurobiology (H.-J.H., M.A.S.), Magdeburg; Kliniken Schmieder (M.A.S.), Allensbach, Germany; and Quantitative Neuroimaging Group (P.B.), Academic Unit of Neurology, Trinity College Dublin, Ireland.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sibylle Jakubiczka
From the German Center for Neurodegenerative Diseases (J.M., S.A., H.-J.H., S.V.), Magdeburg; Departments of Neurology (J.M., K.L., J.K., S.A., H.-J.H., S.V., M.A.S.) and Knowledge and Language Processing (K.L.), and Institute for Human Genetics (S.J.), Otto-von-Guericke University, Magdeburg; Department of Neurology (S.A., S.P., R.D.), Hannover Medical School; Leibniz Institute for Neurobiology (H.-J.H., M.A.S.), Magdeburg; Kliniken Schmieder (M.A.S.), Allensbach, Germany; and Quantitative Neuroimaging Group (P.B.), Academic Unit of Neurology, Trinity College Dublin, Ireland.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susanne Abdulla
From the German Center for Neurodegenerative Diseases (J.M., S.A., H.-J.H., S.V.), Magdeburg; Departments of Neurology (J.M., K.L., J.K., S.A., H.-J.H., S.V., M.A.S.) and Knowledge and Language Processing (K.L.), and Institute for Human Genetics (S.J.), Otto-von-Guericke University, Magdeburg; Department of Neurology (S.A., S.P., R.D.), Hannover Medical School; Leibniz Institute for Neurobiology (H.-J.H., M.A.S.), Magdeburg; Kliniken Schmieder (M.A.S.), Allensbach, Germany; and Quantitative Neuroimaging Group (P.B.), Academic Unit of Neurology, Trinity College Dublin, Ireland.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susanne Petri
From the German Center for Neurodegenerative Diseases (J.M., S.A., H.-J.H., S.V.), Magdeburg; Departments of Neurology (J.M., K.L., J.K., S.A., H.-J.H., S.V., M.A.S.) and Knowledge and Language Processing (K.L.), and Institute for Human Genetics (S.J.), Otto-von-Guericke University, Magdeburg; Department of Neurology (S.A., S.P., R.D.), Hannover Medical School; Leibniz Institute for Neurobiology (H.-J.H., M.A.S.), Magdeburg; Kliniken Schmieder (M.A.S.), Allensbach, Germany; and Quantitative Neuroimaging Group (P.B.), Academic Unit of Neurology, Trinity College Dublin, Ireland.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reinhard Dengler
From the German Center for Neurodegenerative Diseases (J.M., S.A., H.-J.H., S.V.), Magdeburg; Departments of Neurology (J.M., K.L., J.K., S.A., H.-J.H., S.V., M.A.S.) and Knowledge and Language Processing (K.L.), and Institute for Human Genetics (S.J.), Otto-von-Guericke University, Magdeburg; Department of Neurology (S.A., S.P., R.D.), Hannover Medical School; Leibniz Institute for Neurobiology (H.-J.H., M.A.S.), Magdeburg; Kliniken Schmieder (M.A.S.), Allensbach, Germany; and Quantitative Neuroimaging Group (P.B.), Academic Unit of Neurology, Trinity College Dublin, Ireland.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans-Jochen Heinze
From the German Center for Neurodegenerative Diseases (J.M., S.A., H.-J.H., S.V.), Magdeburg; Departments of Neurology (J.M., K.L., J.K., S.A., H.-J.H., S.V., M.A.S.) and Knowledge and Language Processing (K.L.), and Institute for Human Genetics (S.J.), Otto-von-Guericke University, Magdeburg; Department of Neurology (S.A., S.P., R.D.), Hannover Medical School; Leibniz Institute for Neurobiology (H.-J.H., M.A.S.), Magdeburg; Kliniken Schmieder (M.A.S.), Allensbach, Germany; and Quantitative Neuroimaging Group (P.B.), Academic Unit of Neurology, Trinity College Dublin, Ireland.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Vielhaber
From the German Center for Neurodegenerative Diseases (J.M., S.A., H.-J.H., S.V.), Magdeburg; Departments of Neurology (J.M., K.L., J.K., S.A., H.-J.H., S.V., M.A.S.) and Knowledge and Language Processing (K.L.), and Institute for Human Genetics (S.J.), Otto-von-Guericke University, Magdeburg; Department of Neurology (S.A., S.P., R.D.), Hannover Medical School; Leibniz Institute for Neurobiology (H.-J.H., M.A.S.), Magdeburg; Kliniken Schmieder (M.A.S.), Allensbach, Germany; and Quantitative Neuroimaging Group (P.B.), Academic Unit of Neurology, Trinity College Dublin, Ireland.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mircea Ariel Schoenfeld
From the German Center for Neurodegenerative Diseases (J.M., S.A., H.-J.H., S.V.), Magdeburg; Departments of Neurology (J.M., K.L., J.K., S.A., H.-J.H., S.V., M.A.S.) and Knowledge and Language Processing (K.L.), and Institute for Human Genetics (S.J.), Otto-von-Guericke University, Magdeburg; Department of Neurology (S.A., S.P., R.D.), Hannover Medical School; Leibniz Institute for Neurobiology (H.-J.H., M.A.S.), Magdeburg; Kliniken Schmieder (M.A.S.), Allensbach, Germany; and Quantitative Neuroimaging Group (P.B.), Academic Unit of Neurology, Trinity College Dublin, Ireland.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Bede
From the German Center for Neurodegenerative Diseases (J.M., S.A., H.-J.H., S.V.), Magdeburg; Departments of Neurology (J.M., K.L., J.K., S.A., H.-J.H., S.V., M.A.S.) and Knowledge and Language Processing (K.L.), and Institute for Human Genetics (S.J.), Otto-von-Guericke University, Magdeburg; Department of Neurology (S.A., S.P., R.D.), Hannover Medical School; Leibniz Institute for Neurobiology (H.-J.H., M.A.S.), Magdeburg; Kliniken Schmieder (M.A.S.), Allensbach, Germany; and Quantitative Neuroimaging Group (P.B.), Academic Unit of Neurology, Trinity College Dublin, Ireland.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Basal ganglia pathology in ALS is associated with neuropsychological deficits
Judith Machts, Kristian Loewe, Joern Kaufmann, Sibylle Jakubiczka, Susanne Abdulla, Susanne Petri, Reinhard Dengler, Hans-Jochen Heinze, Stefan Vielhaber, Mircea Ariel Schoenfeld, Peter Bede
Neurology Oct 2015, 85 (15) 1301-1309; DOI: 10.1212/WNL.0000000000002017

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
269

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Abstract

Objectives: To evaluate basal ganglia changes along the amyotrophic lateral sclerosis (ALS)–ALS–frontotemporal dementia (FTD) continuum using multiple, complementary imaging techniques.

Methods: Sixty-seven C9orf72-negative patients with ALS and 39 healthy controls were included in a cross-sectional quantitative MRI study. Seven patients with ALS met criteria for comorbid behavioral variant FTD (ALS-FTD), 18 patients met the Strong criteria for cognitive and/or behavioral impairment (ALS-Plus), and 42 patients had no cognitive impairment (ALS-Nci). Volumetric, shape, and density analyses were performed for the thalamus, amygdala, nucleus accumbens, hippocampus, caudate nucleus, pallidum, and putamen.

Results: Significant basal ganglia volume differences were identified between the study groups. Shape analysis revealed distinct atrophy patterns in the amygdala in patients with ALS-Nci and in the hippocampus in patients with ALS-Plus in comparison with controls. Patients with ALS-FTD exhibited pathologic changes in the bilateral thalami, putamina, pallida, hippocampi, caudate, and accumbens nuclei in comparison with all other study groups. A preferential vulnerability has been identified within basal ganglia subregions, which connect directly to key cortical sites of ALS pathology. While the anatomical patterns were analogous, the degree of volumetric, shape, and density changes confirmed incremental pathology through the spectrum of ALS-Nci, ALS-Plus, to ALS-FTD. Performance on verbal memory tests correlated with hippocampal volumes, and accumbens nuclei volumes showed a negative correlation with apathy scores.

Conclusions: We demonstrate correlations between basal ganglia measures and structure-specific neuropsychological performance and a gradient of incremental basal ganglia pathology across the ALS–ALS-FTD spectrum, suggesting that the degree of subcortical gray matter pathology in C9orf72-negative ALS is closely associated with neuropsychological changes.

GLOSSARY

ALS=
amyotrophic lateral sclerosis;
ALS-bi=
amyotrophic lateral sclerosis with behavioral impairment;
ALS-ci=
amyotrophic lateral sclerosis with cognitive impairment;
ALSFRS-R=
ALS Functional Rating Scale–Revised;
ALS-Nci=
amyotrophic lateral sclerosis with no cognitive impairment;
ALS-Plus=
amyotrophic lateral sclerosis with cognitive and/or behavioral impairment;
FSL=
FMRIB's Software Library;
FTD=
frontotemporal dementia;
pTDP-43=
phosphorylated TAR DNA-binding protein 43;
ROI=
region of interest;
TIV=
total intracranial volume

Footnotes

  • Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

  • Supplemental data at Neurology.org

  • Received January 12, 2015.
  • Accepted in final form June 18, 2015.
  • © 2015 American Academy of Neurology
View Full Text

AAN Members

We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.

Google Safari Microsoft Edge Firefox

Click here to login

AAN Non-Member Subscribers

Click here to login

Purchase access

For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)

Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here 

Purchase
Individual access to articles is available through the Add to Cart option on the article page.  Access for 1 day (from the computer you are currently using) is US$ 39.00.  Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means.  The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use.  Distributing copies (electronic or otherwise) of the article is not allowed.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • GLOSSARY
    • METHODS
    • RESULTS
    • DISCUSSION
    • AUTHOR CONTRIBUTIONS
    • STUDY FUNDING
    • DISCLOSURE
    • ACKNOWLEDGMENT
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
Advertisement

Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging

Dr. Ann Yeh and Dr. Daniela Castillo Villagrán

► Watch

Topics Discussed

  • All Neuropsychology/Behavior
  • MRI
  • Amyotrophic lateral sclerosis
  • Frontotemporal dementia

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Article
    Multimodal longitudinal study of structural brain involvement in amyotrophic lateral sclerosis
    Hannelore K. van der Burgh, Henk-Jan Westeneng, Renée Walhout et al.
    Neurology, May 15, 2020
  • Article
    Basal ganglia involvement in amyotrophic lateral sclerosis
    Peter Bede, Marwa Elamin, Susan Byrne et al.
    Neurology, November 08, 2013
  • Articles
    Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis
    N. Filippini, G. Douaud, C.E. Mackay et al.
    Neurology, November 01, 2010
  • Article
    Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis
    Benjamin J. Murdock, Diane E. Bender, Samy R. Kashlan et al.
    Neurology: Neuroimmunology & Neuroinflammation, June 01, 2016
Neurology: 101 (12)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise